1.. Introduction {#S1}
================

Hydrogen sulfide (H~2~S) is a highly neurotoxic colorless gas with a "rotten egg" odor ([@R7]). It is as an environmental pollutant and an occupational hazard in a variety of industries including the oil and gas industry, intensive animal farming operations, sewer and waste water treatment plants, pulp and paper plants, and gas storage facilities, among several others ([@R7]). It is the second leading cause of fatal gas exposure in the workplace after carbon monoxide ([@R18]). It is estimated that there are \> 1000 reports of human exposures to H~2~S each year in the United States ([@R7]). Besides exposures under environmental and industrial settings, intentional H~2~Spoisoning for suicide has recently increased in Western and Asian societies ([@R35]; [@R37]). This is possible because raw chemical ingredients used to generate H~2~S for suicide are readily accessible in local stores ([@R35]). Also law enforcement and first responders called to help, as well as innocent bystanders are at risk of acute exposure to H~2~S ([@R40]). H~2~S was previously developed as a chemical weapon ([@R15]). There are concerns of potential nefarious use of this gas by terrorists, particularly in confined spaces, such as underground transit systems. For this reason, H~2~S has been identified as a priority chemical for research by the US Department of Homeland security ([@R41]). The central nervous system (CNS) is the primary target organ of acute H~2~S-intoxication and neurotoxicity is the primary cause of death ([@R44]; [@R45]; [@R43]; [@R19]). Short-term effects of acute H~2~S poisoning by inhalation include knockdown, seizures, dyspnea, comma, and death. Currently, there is consensus that survivors of acute H~2~S poisoning develop neurological sequelae, which can be incapacitating and last many years often leading to disability ([@R44]; [@R43]; [@R19]). A number of neurological sequelae have been reported. These include dizziness, vertigo, ataxia with tendency to fall, insomnia, fatigue, anxiety, learning and cognition deficits, hearing impairment, recurrent seizures, lack of libido, and increased sensitivity to H~2~S, among others ([@R44]; [@R45]; [@R43]). Extreme cases progress to permanent vegetative states. Neurotoxicity, is manifested in individuals acutely exposed to H~2~S at concentrations \> 500 ppm ([@R43]; [@R19]; [@R39]).

Currently, there are no FDA approved drugs for treatment of either short-term or long-term effects of acute H~2~S-induced neurotoxicity. The development of effective therapeutics requires a good understanding of the molecular mechanisms and pathways of acute H~2~S-inducedneurotoxicity. These mechanisms remain largely unknown. There is an acute need for countermeasures for treatment of mass civilian casualties of acute H~2~S poisoning in the field, such as following catastrophic industrial meltdowns or intentional terrorist activities. Elucidating molecular mechanisms underlying H~2~S-induced neurotoxicity is essential in identifying suitable therapeutic targets to counter both immediate and delayed neurotoxic effects of acute H~2~S poisoning in humans.

We recently developed an inhalation mouse model of acute H~2~S intoxication that exhibits key phenotypes of short- and long-term effects of acute H~2~S poisoning in victims and survivors ([@R2]). Briefly, this model is unique because normal walking mice without anesthesia are exposed to H~2~S by inhalation, recapitulating the typical exposure scenario, following accidents, or during suicide. Clinically, mice suddenly collapse, have seizures, and are dyspneic during exposure. Surviving mice manifest motor deficits on rotarod and open field tests, and developed neurodegeneration, faithfully recapitulating the human condition. The objective of this study was to use this mouse model to investigate proteomic changes following acute H~2~S-exposure to identify novel toxic mechanisms that could potentially be targeted for therapeutic intervention. These studies focused on the central inferior colliculus (IC), part of the brainstem, because our previous studies revealed this to be the most sensitive brain region to H~2~S-induced neurodegeneration ([@R2]). However, we also previously observed histopathological changes in other parts of the brain, especially the thalamus and cortex ([@R2]). This ground breaking H~2~S-study demonstrated, for the first time, that H~2~S exposure induces significant proteomic changes in the IC, including albumin (Alb) leakage, neuroinflammation, and oxidative stress, which collectively play an important role in the execution of H~2~S-induced neurotoxicity and neurodegeneration.

2.. Materials and methods {#S2}
=========================

2.1.. Materials {#S3}
---------------

H~2~S gas was purchased from Airgas (La Porte, TX). RNeasy mini kit was purchased from Qiagen (Germantown, MD). High Capacity cDNA RT kit were purchased from ThermoFisher Scientific (Waltham, MA). RT^2^ SYBR Green ROX qPCR Mastermix and primers for Gapdh were purchased from Qiagen (Valencia, CA). Primary antibodies against Alb, hypoxia inducing factor 1 alpha (Hif-1α), and Vimentin (Vim) were purchased from Cell signaling (Danvers, MA). Primary antibodies against nuclear factor-like 2 (Nrf2) and 3-Oxoacid CoA Transferase 1 (Oxctl) were purchased from Abeam (Cambridge, MA). Primary antibody against Fas was purchased from SantaCruz Biotechnology (SantaCruz, CA). Primary antibody against NeuN was purchased from Millipore (Billerica, MA). U-PLEX combo kit against TNF-α was purchased from Meso Scale Diagnostics (Rockville, MD).

2.2.. Animals and treatment {#S4}
---------------------------

This study was approved by Iowa State University Animal Care and Use Committee. Seven- to eight-week-old male C57 BL/6 J mice were used because previous studies from our lab showed that males were more sensitive than females. The mice were housed at room temperature of 20--22 °C under a 12-h light cycle, and a relative humidity of 35--50%. Protein rodent maintenance diet (Teklad HSD Inc., WI, US) and water were provided ad libitum. Prior to H~2~S exposure on day 1, all mice were acclimated to breathing air for 40 min for two consecutive days. Freely moving unanesthetized mice were exposed either to normal breathing air (Control) or to 650--750 ppm H~2~S (H~2~S-treated) either once or to 2--7 short-term exposures. Both breathing air and H~2~S were supplied from compressed gas cylinders. The inhalation dosage of H~2~S was selected basing on published literature indicating concentrations of H~2~S \> 500 ppm are associated with knockdown and neurotoxicity in human ([@R43]; [@R19]; [@R39]). Typically, humans are exposed once, but repeated exposures have been reported ([@R1]). For purposes of studying the progression of neurotoxicity, separate groups of mice in this study were euthanized after receiving either only one or 2--7 acute exposures. For proteomic studies, the first batch of mice was terminated on the first day, day 1, only 2 h post exposure. Others were terminated on days 2 and 4. Negative controls were exposed to normal breathing air daily and euthanized on day 4. The gas exposure paradigm is summarized in [Fig. 1](#F1){ref-type="fig"}. Animals were cared for in accordance with the Institutional Animal Care and Use committee guidelines.

2.3.. Behavioral assessment {#S5}
---------------------------

The VersaMax open field test was used to assess motor deficits induced by H~2~S. We used this test because previous studies in the lab had indicated it to be sensitive to acute H~2~S intoxication in this mouse model ([@R2]). Ataxia and other movement disorders are frequently reported neurological sequelae in survivors of acute H~2~S poisoning ([@R1]; [@R44]; [@R45]). Spontaneous activity was measured using an automated computer device (Model RXYZCM-16; Accuscan, Columbus, OH, USA). The activity chamber's dimensions are 40 × 40 × 30.5 cm, and it is made of Plexiglas with a Plexiglas lid. The lid has holes for ventilation. Data was analyzed using VersaMax Analyzer (Model CDA-8; Accuscan). Mice were placed in the activity chamber for acclimation 2 min prior to recording for 10 min. Vertical activity, horizontal activity, and distance traveled were measured.

2.4.. Histopathology and immunohistochemistry {#S6}
---------------------------------------------

Mice were euthanized 2 h after the last H~2~S exposure. They were deeply anesthetized with a cocktail of 100 mg/kg BW ketamine and 10 mg/kg BW xylazine via intraperitoneal (IP) injection. The thoracic cavity was opened to expose the heart and fresh 4% paraformaldehyde (PFA, pH 7.4) was injected through the left ventricle. After perfusion, the skull was opened and brains were post-fixed in 4% PFA for 24--48 h before removal from the skull. Brains were processed in paraffin, sectioned at 5 μm, and stained with hematoxylin and eosin (H&E), and examined microscopically. Immunohistochemistry was used to visualize live and degenerating neurons. Neurons were stained with NeuN antibody (abl77487, Abeam, Cambridge, MA) using an indirect immunostaining protocol. Diaminobenzidine was used as chromogen. Stained sections were examined using a Nikon Eclipse Ci-L microscope equipped with a DS-Fi2 camera. For image analysis to count neurons, NeuN-positive cells (sites of DAB chromogen deposition) were enumerated in each of five 400× photomicrographs of the IC from mice exposed to H~2~S or breathing air, and the mean number of NeuN-positive cells were compared between groups. Degenerating and dying neurons were identified by Fluoro-Jade C staining. Briefly, deparaffinized, hydrated sections were incubated in 0.06% potassium permanganate solution for 10 min, rinsed for 2 min in distilled water and incubated in a 0.0001% solution of Fluoro-Jade C (Histo-Chem, Inc., Jefferson, AR) for 10 min at room temperature. Dark conditions were maintained after application of Fluoro-Jade C to prevent photobleaching. Sections were rinsed three times in distilled water, incubated at 4 °C in 6-diamidino-2-phenylindole (DAPI, Sigma, St. Louis, MO), rinsed, air-dried and cover slipped using DPX non-fluorescent mounting medium (Sigma, St. Louis, MO). Sections were examined using an EVOS FL Cell Imaging System (ThermoFisher Scientific).

2.5.. Mass spectrometry proteomic analysis {#S7}
------------------------------------------

Mice were euthanized by decapitation 2 h after the last exposure to H~2~S on days 1, 2 and 4 for proteomics analysis, quantitative gene expression analysis by real-time PCR, and by Western blot. Following decapitation, brains were immediately removed from the skull. The IC was microdissected on ice and immediately flash-frozen using liquid nitrogen, and stored at −80 °C until further use. Samples were processed according to a previously published method with some modifications ([@R34]). Briefly, IC tissues were placed in 100 μL of urea lysis buffer and homogenized with a handheld pestle homogenizer. Protein samples were further reduced and alkylated. Small aliquots of each sample were taken to measure protein concentration using the Bradford assay from Bio-Rad (Hercules, CA). The remaining samples were diluted and trypsin-digested overnight, followed by desalting using a C18 peptide trap from Michrom (Auburn, CA). The desalted samples were vacufuged prior to individual sample labeling using TMT-6plex labels according to the manufacturers' instructions (Thermo Fisher Scientific, Waltham, MA). Labeled samples of each exposure group were combined with the control for sample comparison ([Table 1](#T1){ref-type="table"}). Peptides were separated on a Waters BEH C18 capillary column prior to online analysis using a 240-min linear increasing gradient of acetonitrile with 0.1% formic acid. Following elution from the column, ions were generated using 2.6 kV on a taper tip in a New Objective Nanosource and entered into an LTQ-OrbitrapVelos mass spectrometer (Thermo Fisher, San Jose, CA). A full scan was taken in the LTQ, followed by data-dependent MS/MS analysis of the top 6 peaks. MS/MS analysis included collision-induced dissociation (CID) in the LTQ for structural information and higher-energy collisional dissociation (HCD) in the Orbitrap for quantitation. MS/MS data were aligned and quantitated using MaxQuantl.5.4.1 ([@R8]) Analytics Platform with PTXQC ([@R4]) quality control data management. Peptide alignment was executed with the mouse Uniprot protein database UP000000589_10090.fasta; enzyme: trypsin; carboxymethyl (C), and oxidation (M), FDR \< 1% based on peptide q-value under standard settings (see supplemental data). The secondary computational analysis was executed using Perseus 1.5.5.3 ([@R46]) for statistical rendering, and web-based software Morpheus for heatmap rendering. Prior to analysis of experimental samples, small aliquots of individually labeled control samples were analyzed to determine individual variations in controls. Due to low variability in the controls, a pooled control setting was used. Sample analysis included modification of the MaxQuant protein output list by normalization of individual TMT reporter ion intensities by division through the median intensity followed by determination of fold TMT expression ratios by division of individual experimental TMT values (126,127,128,129,and 130) through the TMT value (131) of the pooled control.

2.6.. Perseus statistical analysis {#S8}
----------------------------------

The previously modified Maxquant protein list was entered into the Perseus 1.5.5.3 software program followed by annotating Maxquant defined Swissprot protein accession numbers with mouse gene identifiers. Statistical analysis included one-sample *t*-tests of fold expression values by considering the deviation of samples from 1 fold expression (no change in TMT reporter ion intensities vs. control intensity values) using *p* \< .05 as a criterion for significance. Scatter Plots were established by plotting one-sample *t*-test difference fold protein expression vs. --log one-sample *t*-test *p* value fold protein expression according to the associated Perseus tool set.

2.7.. Morpheus Heatmap rendering {#S9}
--------------------------------

The Perseus processed protein list containing mouse gene identifiers, protein names and gene ontology (GO) biological process, one-sample t-test, levels of significantly and non-significantly modulated proteins was entered into the web-based Morpheus heatmap-rendering tool (<https://software.broadinstitute.org/morpheus/>). A gradient coloring scheme was applied to display upregulated (above 1.2 fold expression (in log2 display above 0.263), red color) vs. downregulated (below 0.83 fold expression (in log2 display below −0.263) blue color) protein nodes. White color nodes represent changes of non-modulated nodes to control levels (between 0.83 and 1.2 fold expression). Normalization of individual TMT reporter ion intensities was done by division through the median intensity followed by determination of fold TMT expression ratios by division of individual experimental TMT values (126,127,128,129,and 130) through the TMT value (131) of the pooled control. The cut-off limit of 1.2 fold was chosen because these individual values are already highly normalized expression values and the maximum fold values achieved were below 2.5. A 1.2 fold cut-off value was used as in a previous publication ([@R34]). The heatmap was hierarchically clustered by Euclidean distance using row average linkage and grouping of rows by GO biological process. Functional enrichment analysis was performed using Webgestalt pathway overrepresentation enrichment analysis with Panther engine (<http://www.webgestalt.org/option.php>). Up to ten highest probable pathways for each time point of H~2~S treatment data were presented.

2.8.. Western blot assay {#S10}
------------------------

Microdissected tissue samples were lysed in modified RIPA lysis buffer (1% Triton X-100, ImM EDTA, 100 mM NaCl, ImM EGTA, 1 mM NaF, 20 mM Na4P207, 2mM Na3V04, 10% glycerol, 0.1% SDS, 0.5% deoxycholate, 50 mM Tris-HCl, and pH 7.4) via sonication, followed by centrifugation as described previously ([@R27]). After protein concentration of samples were measured using the Bradford assay, equal amounts of protein samples were loaded to a 10--12% SDS-PAGE gel and transferred onto a nitrocellulose membrane. The membranes were blocked with 5% bovine serum albumin in TBS supplemented with 0.1% Tween-20. Specific primary antibodies were incubated with the membrane overnight at 4 °C. After rinsing thoroughly in PBS supplemented with 0.1% Tween-20, the membrane was incubated with secondary antibodies. β-Actin antibody was used for loading control. Immunoblot imaging was performed with an Odyssey Infrared Imaging system (LI-COR, Lincoln, NE). ImageJ software (National Institutes of Health, Bethesda, MD) was used to quantify western blot bands.

2.9.. Enzyme-linked immunosorbent assay {#S11}
---------------------------------------

Microdissected tissue samples were immediately frozen. Samples were lysed in modified RIPA lysis buffer (150 mM NaCl, 20 mM Tris pH 7.5, 1 mM EGTA, 1 mM EDTA, 1% NP-40, 0.1% SDS) with protease inhibitors via sonication ([@R10]; [@R21]). Lysed samples were centrifuged at 10,000 × *g* for 10 min at 4 °C. Expression of TNFα was measured using Meso Scale Discovery system following manufacturer's protocol.

2.10.. Quantitative real-time RT-PCR {#S12}
------------------------------------

Following exposure to H~2~S, tissues were dissected and immediately stored at −80 °C till analysis. Total RNA was extracted from frozen tissues using the RNeasy^®^ Plus Mini kit with treatment of DNase I according to the manufacturer's protocol. Validated primers for Gapdh (Qiagen, \#PPR57734E) were used as the housekeeping gene controls. The threshold cycle (C~t~) was calculated from the instrument software, and fold change in gene expression was calculated using the ΔΔ~t~ method as described earlier ([@R27]). The following primers were used to check the quantitative transcriptional level of Prkab1, Vim, and Ahsal; 5′-TCCGATGTGTCTGAGCTGTC-3′ and 5′-CCCGTGTCCTTGTTCAAGAT-3′ for Prkab1 ([@R3]), 5′-TCCACACGCACCTACAGTCT-3′ and 5′-CCGAGGACCGGGTCACATA-3′ for Vim ([@R47]), 5′-CAGAGGGGCACTTTGCCACCA-3′ and 5′-CACGGCCTTCCATGCACAGCT-3′ for Ahsal.

2.11.. Statistical analysis {#S13}
---------------------------

Data were analyzed using Prism 4.0 (GraphPad Software, San Diego, CA). Non-paired Student's *t*-test was used when two groups were being compared. Differences were considered statistically significant for *p*-values \< 0.05. Data are represented as the mean ± S.E.M. of at least two separate experiments performed at least in triplicate.

3.. Results {#S14}
===========

3.1.. Acute exposure to H~2~S induces motor behavioral deficits and seizures in C57 black mice {#S15}
----------------------------------------------------------------------------------------------

Locomotor activities of mice were assessed on days 2, 4, and 6. Results indicated that the horizontal and vertical activities were decreased by \> 50% and were statistically different in mice exposed to H~2~S compared to those that received breathing air ([Fig. 2A and B](#F2){ref-type="fig"}). Total distance traveled was also decreased by \> 50% and was also statistically different in H~2~S-exposed mice compared to controls ([Fig. 2C](#F2){ref-type="fig"}). Most importantly, mice exposed to H~2~S exhibited severe seizure activity. On day 1, during the first exposure, seizure activity was observed, on average, starting at 15 min of H~2~S exposure. More than 50% of mice had seizures at 40 min of exposure. We also observed that mice that were exposed to H~2~S on subsequent days were more sensitive to H~2~S than naive mice. For example, mice exposed to H~2~S more than once had seizures after only 5 min of H~2~S exposure compared to 15 min for naive mice. Also, consistent with increased sensitivity, 40% of the mice exhibited seizures at 10 min of H~2~S exposure on day 6 compared to about 40 min in naive mice on day 1. Collectively, these results indicate increased susceptibility of mice to H~2~S after each successive H~2~S exposures, suggesting that the toxic effects of H~2~S exposure are cumulative ([Fig. 2D](#F2){ref-type="fig"}).

3.2.. Acute hydrogen sulfide exposure induced brain damage {#S16}
----------------------------------------------------------

Motor behavioral deficits induced by exposure to H~2~S may be a sign of injury to the CNS. Therefore, histopathology was performed to identify the effects of H~2~S exposure in the IC. Mice were exposed to H~2~S as designated in [Fig. 1](#F1){ref-type="fig"}. For this portion of the study, in order to assess the progression of neuropathology, mice were sacrificed at multiple time points (2 h, days 3 or 7). Microscopic examination of PFA-perfused brains revealed H~2~S-induced neurodegeneration and loss of neurons in the IC ([Fig. 3A](#F3){ref-type="fig"}). By day 7, mice exposed to H~2~S exhibited severe lesions in the IC, with necrosis, vacuolar change, and infiltration by neuroglial cells. H~2~S exposure frequently induced hemorrhage in IC ([Fig. 3B](#F3){ref-type="fig"}). In order to further characterize and quantify the loss of neurons, IC tissues were analyzed by immunohistochemical staining using the neuron specific marker, NeuN. On day 7, there was a marked loss of neurons in the IC of H~2~S-exposed mice, compared with the breathing air group. Enumeration of neurons in the IC revealed approximately a 70% loss of IC neurons by day 7 of H~2~S exposure ([Fig. 3C and D](#F3){ref-type="fig"}) with infiltration by glial cells. However, in H~2~S exposed mice, neurons in the midbrain region adjacent to the IC appeared unaffected morphologically and glial cell numbers and activation state were not altered. Neurodegeneration was further confirmed using Fluoro-Jade C staining in the IC of H~2~S-exposed mice ([Fig. 3E](#F3){ref-type="fig"}). There was an increase in Fluoro-Jade C positive degenerating neurons in the IC. A reduction in numbers of NeuN positive cells and an increase in population of Fluoro-Jade C stained cells demonstrate H~2~S-induced selective loss of neurons and neurodegeneration in the IC.

3.3.. Acute H~2~S exposure caused changes in the broad spectrum proteome {#S17}
------------------------------------------------------------------------

Proteomic profiles of the IC were determined using TMT peptide labeling coupled with LC/MS/MS analysis by comparison of the breathing air negative control group and the H~2~S exposed group is described in the methods section. Mass spectrophotometry analysis was able to identify 598, 562, and 546 altered proteins for 2 h, days, 2 and 4 of H~2~S exposure, respectively. Subsequent analyses showed alterations of protein expressions ([Fig. 4](#F4){ref-type="fig"}, heatmap) with 36, 12 and 14 proteins being significantly downregulated (below 0.83 fold) and 9, 7, and 13 proteins being significantly upregulated (above 1.2 fold) compared to the control for 2 h and days 2 and 4 of H~2~S exposure, respectively. The cut-off limit of 1.2 fold was chosen because individual experimental TMT values for each sample were highly normalized as described above and has been used in previous publication ([@R34]). A single H~2~S exposure, in which mice were euthanized only 2 h post exposure on day 1, demonstrated the highest range of fold protein expression changes compared to the control with the majority of proteins being in the downregulation cluster. This was followed by day 2, in which mice received only 2 acute exposures, with equal distribution of upregulated and downregulated proteins, while mice euthanized on day 4 manifested the lowest range of fold changes with the least changes in the proteomic profile ([Fig. 5A, B, C, D](#F5){ref-type="fig"}, scatter plots). Several proteins including cytoplasmic FMR1-interacting protein 2 (Cyfip2), Alb, and hemoglobin subunit proteins were increased on all three time-points, while some proteins including activator of HSP90 ATPase activity 1 (Ahsal) were consistently downregulated at the three time-points ([Fig. 4](#F4){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). Scatter plots to show overall distribution of proteomic profile changes in the IC following H~2~S exposure are shown in [Fig. 5](#F5){ref-type="fig"}. [Fig. 5](#F5){ref-type="fig"} display is a common method to display proteomics data.

3.4.. Validation of proteomic changes of genes after H~2~S exposure {#S18}
-------------------------------------------------------------------

To confirm the observed changes in the IC proteomic profile following acute exposure to H~2~S, several genes were analyzed by Western blot or quantitative RT-PCR analysis. Mice were sacrificed on each designated time points to measure cellular response. The rationale for selection of proteomic changes for verification was based on a; proteomic changes which were consistently up or down regulated; and b) proteomic changes which fit the overall hypothesis of H~2~S-induced neurotoxicity.

H~2~S exposure consistently induced protein expression of Alb in proteomic analysis at 2 h, days 2 and 4. Alb, a major blood protein, is mainly produced in liver ([@R11]). The Western blot analysis showed increased protein expression of Alb in the IC in H~2~S-exposed mice ([Fig. 6A](#F6){ref-type="fig"}). Oxctl is a homodimeric mitochondrial matrix enzyme in the 3-oxoacid CoA-transferase gene family. Oxctl protein was increased in IC of H~2~S exposed mice ([Fig. 6B](#F6){ref-type="fig"}). Vim encodes intermediate filaments and is part of cytoskeleton ([@R6]). It signals neuroinflammation ([@R32]). To confirm potential H~2~S exposure dependent pro-inflammatory and ischemic effects, mRNA expression of Vim was measured. Vim mRNA expression demonstrated a steady increase at 2 h through day 4 ([Fig. 7B](#F7){ref-type="fig"}). This supports the increased protein expression of Vim at 2h. The increased mRNA expression of Vim was consistent with increased Vim protein expression on days 3 and 7 ([Fig. 6C](#F6){ref-type="fig"}).

Protein kinase AMP-activated non-catalytic subunit beta 1 (Prkab1) is known to correlate with calcium fluctuations as a measure of cellular calcium response ([@R49]). Due to unavailability of reliable antibody for the specific Prkab1, Prkab1 mRNA expression was analyzed as a means to measure the calcium-dependent cellular response following H~2~S exposure. Prkab1 mRNA expression was upregulated following H~2~S exposure on 2 h and days 2 and 4 which is in line with the mass spectrophotometry analysis observed upregulation of protein Kinase cAMP-activated catalytic subunit alpha (Prkca) and calcium activated protein kinase C beta (Prkacb) on exposure 2 h.

We observed downregulation of Ahsal at 2 h and on day 2 in proteomic profile analysis. Expression of Ahsal was examined by RT-PCR ([Fig. 7C](#F7){ref-type="fig"}). Similar to the protein expression of Ahsal in proteomic profile analysis, mRNA expression of Ahsal demonstrated a significant 30--40% downregulation on 2 h and day 2, compared to the breathing air control group.

3.5.. H~2~S exposure induced signaling pathways in IC {#S19}
-----------------------------------------------------

We further analyzed H~2~S-dependent alterations in the proteome using Webgestalt pathway overrepresentation enrichment analysis with Panther engine and displayed the 10 highest probable pathways for each day of treatment, when applicable, by integrating gene cards information ([www.genecards.org](http://www.genecards.org)). Using this approach, we found that several molecular pathways were involved in H~2~S-induced neurotoxicity ([Table 3](#T3){ref-type="table"}). Acute exposure to H~2~S resulted in alteration of metabotropic glutamate receptor group I pathway, endothelin signaling pathway, inflammation mediated by chemokine and cytokine signaling pathway, and glycolysis at 2 h and on day 2. Fas signaling pathway, gonadotropin-releasing hormone receptor pathway, and cytoskeletal regulation by Rho GTPase pathway were altered on day 4. Remarkably, biological pathways involved at 2h and on day 2 were similar, but patterns of altered biological pathways on day 4 were different ([Table 3](#T3){ref-type="table"}). The metabotropic glutamate receptor group 1 pathway, which was shown to be involved during early response of H~2~S exposure at 2h and on day 2, is consistent with our previous findings incriminating dysregulation of glutamate in H~2~S-induced neurotoxicity ([@R2]). These results also underscore the role of neuroinflammation and are consistent with our previously published data incriminating inflammation in the pathogenesis of H~2~S-induced neurotoxicity ([@R2]). In addition, expression of Fas was measured by Western blot to check activation of Fas signaling in H~2~S-induced neurotoxicity ([Fig. 8A](#F8){ref-type="fig"}). The expression of Fas was significantly increased on day 3.

3.6.. H~2~S exposure induced hypoxia, oxidative stress, and inflammatory signaling pathways in the IC {#S20}
-----------------------------------------------------------------------------------------------------

Hypoxia is implicated in H~2~S-induced neurotoxicity, but little or no evidence was presented before ([@R28]; [@R42]). To check if H~2~S exposure activates hypoxic signaling, expression of Hif-1α was measured by Western blot analysis. Expression of Hif-1α was increased 2 fold after a one time exposure and 1.5 fold on days 3 and 7 ([Fig. 8B](#F8){ref-type="fig"}). To examine oxidative stress signaling in H~2~S-induced neurotoxicity, expression of Nrf2 was measured by Western blot analysis ([Fig. 8C](#F8){ref-type="fig"}). Protein expression of Nrf2 was significantly increased at 2 h and on day 3. Functional enrichment analysis showed inflammation response was involved in H~2~S-induced toxicity ([Table 3](#T3){ref-type="table"}). TNF-α is a key pro-inflammatory cytokine. The expression of TNF-α was measured by ELISA and was found significantly increased on day 7 ([Fig. 8D](#F8){ref-type="fig"}).

4.. Discussion {#S21}
==============

Early events involved in acute H~2~S exposure or those leading to persistent neurological sequelae are not well known. Neurological sequelae among human survivors of acute H~2~S poisoning are widely reported ([@R33]; [@R44]; [@R45]; [@R26]; [@R43]; [@R48]). However, the exact cellular and molecular mechanisms underlying the pathogenesis of delayed neurological sequelae after acute H~2~S exposure are poorly understood. We have previously identified and herein confirmed that the IC in the brainstem region is highly sensitive to H~2~S-induced neurodegeneration ([@R2]).

The relative sensitivity of the IC to H~2~S-induced injury reflects the unique elements and cell populations in this region of the brain. We observed histologic features of neurodegeneration including neuronal death, and reactive gliosis in the IC starting on day 3. Massive cell necrosis and glial scarring were noted in the IC on day 7. Immunohistochemistry with neuron specific antibody (NeuN) revealed severe neuronal loss in the IC following H~2~S exposure. Whereas neuronal loss was minimal in mice from the breathing air control group, there was \> 70% loss in neurons in IC of mice exposed to H~2~S. In contrast, brain stem regions adjacent to the IC were shown to be relatively unaffected, indicating unique susceptibility of the IC region to H~2~S toxicity. The function of the IC is to integrate auditory and other sensory signals. IC is reportedly a region with high metabolic rate requirements ([@R38]; [@R23]) while it is also the most highly vascularized brain region ([@R17]). H~2~S is a systemic metabolic toxicant that reportedly interferes with ATP synthesis. It is reasonable to infer that brain regions with high blood supply and metabolic rates such as the IC are more vulnerable to H~2~S-induced toxicity. Hearing loss is a frequently reported sequelae of acute H~2~S poisoning and these results are consistent with that observation.

In this study, we used proteomic analysis to define cellular and molecular mechanisms of H~2~S induced neurotoxicity and neurodegeneration during early stages of injury. Exposure to H~2~S induced significant proteomic changes in IC. Proteins commonly and constantly upregulated during H~2~S exposure were Cyfip2, hemoglobin subunit alpha (Hba), hemoglobin subunit beta-2 (Hbb-b2), and Alb. In contrast, Ahsal was consistently downregulated on 2h and days 2 and 4. The increased expression of Alb was confirmed by Western blot. Alb is a major blood protein and its presence in the IC suggests a breach of the blood-brain barrier (BBB), leading to protein leakage. Indeed, hemorrhage was observed in IC of mice following H~2~S exposure. Disruption of BBB triggered by a variety of factors has been reported to cause neuroinflammation ([@R14]). This is a preliminary observation and the role of breach of BBB in H~2~S-induced neurotoxicity should be evaluated further in the future. The cause of the BBB breach is beyond the scope of this current study, but we also observed changes in other proteins triggered by hypoxic conditions including adenosine Kinase, Tropomodulin 2, vimentin, Neurogranin, and Poly(RC) binding protein 2. It is possible hypoxia induced the breach in the BBB.

Other key altered molecular biological pathways include metabotropic glutamate receptor group I pathway, inflammation mediated by chemokine and cytokine signaling pathway, and altered glycolysis. We have previously reported that H~2~S increases the glutamate:GABA ratio ([@R2]), an indication that H~2~S may activate glutamate receptors. These results suggesting a role for metabotropic glutamate I pathway in the pathogenesis of H~2~S-induced neurotoxicity is yet more evidence for glutamate-induced excitotoxicity. Glutamate excitotoxicity causes seizures ([@R25]).

H~2~S-induced neurotoxicity has been suggested to resemble brain injury caused by ischemic hypoxic conditions ([@R13]; [@R39]). We observed increased Hif-1α protein expression in IC of H~2~S exposed mice. These results further support the role of hypoxia in H~2~S-induced neurotoxicity. The trigger for hypoxia is likely inhibition of cytochrome *c* oxidase in mitochondria, but this remains to be elucidated. Also, characterizing the downstream cascade of Hif-1α signaling pathway remains to be studied. Regardless, this is the first study to directly tie hypoxia to Hif-1α signaling in H~2~S-induced neurotoxicity. Previous studies have suggested neurofilament Nefl, and collapsing Response Mediator Protein 3 (Dpysl4) as biomarkers of hypoxia and cerebral ischemia ([@R22]; [@R31]). Dpysl4 is cleaved by activated calpain reaction in response to cerebral ischemia ([@R22]). Both Nefl and Dpysl4 were downregulated during H~2~S exposure. In addition, mass spectrophotometry analysis detected downregulation of phosphoglycerate mutase 2 (Pgam2), an ischemia biomarker, on day 1. This biomarker is suggested to correlate with the ischemic conditions ([@R30]). Vimentin (Vim) has been shown as another biomarker for ischemia ([@R29]). Mass spectrophotometry also detected a steady increase in protein and mRNA expression of the inflammatory and ischemia biomarker Vim for the entire duration of the study. These data collectively support H~2~S-dependent ischemia-like conditions during acute H~2~S exposures, further supporting the role of hypoxia as a mechanism of H~2~S-induced neurotoxicity.

It is well known that H~2~S inhibits cytochrome *c* oxidase which plays a crucial role in mitochondrial ATP synthesis ([@R36]; [@R12]). Using variations of this animal model we have consistently shown inhibition of cytochrome *c* oxidase ([@R2]). In this proteomic study, expression levels of cytochrome *c* oxidase-related proteins were not changed, but mitochondrial cytochrome *c* oxidase subunit 2 (mt-Co2) and cytochrome *c* oxidase subunit 6C were decreased at 2 h and on day 4, respectively, supporting the notion of potential impairment of energy production following H~2~S exposure. Several other proteins related to energy production were also altered. For instance, ATP synthase subunits Atp5j2 and ATP51 together with cytochrome C oxidases 6C were downregulated on days 2, and 4, respectively. In addition, citric acid cycle proteins malic enzyme (Mel) and phosphoglycerate mutase (Pgam2) were downregulated on 2 h post a single dose. Oxctl was upregulated on day 2 and 4. Oxctl was upregulated and induced ATP production from ketone bodies when hepatocellular carcinoma were deprived of serum ([@R16]). Increase of Oxctl during H~2~S exposure may indicate a switch from glucose metabolism to alternative sources of ATP production in IC of mice exposed acutely to H~2~S. Further studies are warranted to check whether Coxy6c, mt-Co2, and Oxctl are the bona fide targets of H~2~S toxicity. Collectively, these results suggest hypoxia, resulting in low oxygen tissue delivery, and dysregulation of cytochrome C related proteins, likely working in concert leading to energy deprivation and eventual neuronal death in the IC.

We have previously implicated neuroinflammation in this mouse model of acute H~2~S intoxication ([@R2]). Inflammation mediated by chemokine and cytokine signaling pathway was a key early finding in this study, and strongly upregulated starting 2h following a single acute exposure ([Table 3](#T3){ref-type="table"}). We have previously reported activated astrocytes and microglia following acute H~2~S exposure ([@R2]). Changes in immunogenic biomarkers represent one of earliest responses to cytotoxicity, and inflammation ([@R2]). Expression of TNF-α was shown to be significantly activated and increased in the IC on day 7 of H~2~S exposure. Moreover, anti-inflammatory protein macrophage migration inhibition factor (Mif) was downregulated on 2 h, and complement binding protein Clqbp was increased on day 4. Other pro-inflammatory related proteomic changes observed in this study include upregulations of Cyfip2 and nuclear hormone receptor and transcriptional repressor family (Nr1d2) which were observed throughout the course of the study. Also, increased expression of Cyfip2 was previously shown by others to have a p53-response element in its promoter region and to be one of the direct targets of p53 ([@R24]). In contrast, the anti-apoptotic and immunogenic protein Bcl2 associated athanogene (Bag5) was downregulated at 2 h. Endoplasmic reticulum stress-induced downregulation of Bag5 has previously reported ([@R5]; [@R20]). Furthermore, expression of Fas was increased on day 3. Fas was previously responsible for initiating apoptotic signaling pathways and inflammation response ([@R9]). The exact roles of these molecules in H~2~S-induced neurotoxicity remain to be studied further. However, collectively, these results are consistent with our previous observations that inflammation may play an important role in H~2~S-induced neurotoxicity ([@R2]).

In summary, this seminal proteomic study of the IC from mice acutely H~2~S-intoxicated mice has yielded both novel and supporting results of our previous observations. H~2~S-induced neurotoxicity is complex. A summary of our current overarching hypothesis of acute H~2~S-induced neurotoxicity is summarized in [Fig. 9](#F9){ref-type="fig"}. We have explained how proteomic changes observed in this study fit key nodes of this summary scheme. We have also, to the extent possible, validated select proteomic changes using quantitative RT-PCR and Western blot analyses. Sufficient concordance was observed for the validated proteomic changes using transcript and/or protein expression. A very interesting observation was the close similarity in the top 10 proteomic pathways early in the course of H~2~S-intoxication (2 h and day 2). The study also uncovered novel pathways with a potential role in H~2~S-induced toxicity which we would not have predicted. These include the endothelin signaling pathway, the gonadotropin releasing hormone pathway, and the histamine H2 receptor mediated signaling pathway, among others summarized in [Table 3](#T3){ref-type="table"}. These likely play a role in any of the pathogenesis of multiple sequelae reported following acute H~2~S-intoxication, some of which are listed in [Fig. 9](#F9){ref-type="fig"}. More research is certainly needed to study the role of these novel pathways in acute H~2~S-induced neurotoxicity.

5.. Conclusion {#S22}
==============

In this study we examined the early effects of acute H~2~S-induced neurotoxicity in mice. The study focused on the IC, the most sensitive brain region to acute H~2~S poisoning. Results show that H~2~S modulated several proteins and biological pathways in the IC. Specifically, results suggest glutamate-induced excitotoxicity, immune mediated inflammatory response, pro-apoptosis mechanisms, and hypoxia/ischemia-like signaling to be involved in H~2~S-induced neurotoxicity, among others. These results are in concert with our previously published observations, including dysregulated glutamate and GABA, mitochondrial injury, neuroinflammation and oxidative stress in the pathogenesis of acute H~2~S-induced neurotoxicity. An overall scheme of key events we hypothesize to be involved in the pathogenesis of acute H~2~S induced neurotoxicity is shown in [Fig. 9](#F9){ref-type="fig"}. However, this research has also uncovered novel pathways which potentially may not fit the above scheme. This suggests that acute H~2~S-induced neurotoxicity is a complex process. Further research is recommended to better understand the singular and/or collective role of these potential mechanisms in H~2~S-induced mortality, neurotoxicity, and evolution of neurological sequelae.
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![Acute exposure paradigm of hydrogen sulfide in C57 black mice.\
Mice were exposed to 765 ppm of H~2~S in a chamber for 40 min either once only (day 1) and for 15 min on the subsequent days up to day 7. Mice were sacrificed 2h post-H~2~S exposure on specified days of the study. Negative control mice were exposed to breathing air from a cylinder daily up to day 7. Separate groups of mice were sacrificed on days 1 (2 h post-exposure), 3, and 7 for immunohistochemistry, Western blot assay, and ELISA analysis. Groups of mice for proteomics studies and quantitative RT-PCR analysis were sacrificed on days 1 (2 h post-exposure), 2 and 4.](nihms-1007346-f0001){#F1}

![Acute exposure to hydrogen sulfide induced motor deficits and seizures.\
C57 black mice were exposed to H~2~S as shown in [Fig. 1](#F1){ref-type="fig"}. Locomotor activity was measured using an automated VersaMax locomotor activity monitor for 10 min on days 2, 4, and 6. Horizontal activity (A), vertical activity (B), and total distance traveled (C) were analyzed between groups. For seizures, time to seizure and number of mice seizing were monitored (D). Asterisks (\*, *p* \< 0.05; \*\*, *p* \< 0.01) indicate statistically significant differences between H~2~S and breathing air negative control groups.](nihms-1007346-f0002){#F2}

![Neurodegeneration and necrosis in the IC of mice exposed to 650--750 ppm H~2~S in acute short-term repeated inhalation exposures over 7 days. Note the loss of neurons and development of clear vacuoles in the neuropil (arrow) on day 7 in mice exposed to H~2~S and the minimal morphologic effects to earlier H~2~S exposures or breathing air (A). H~2~S exposure induced hemorrhage (thick arrow) in the IC. An insert at higher magnification is included to show the hemorrhage. Hemorrhage was not seen in control mice (B). NeuN staining in brown color (arrow) of neurons (C). H~2~S caused marked and selective loss of neurons in the IC (1000× magnification images, C), with retention of neurons in the regions surrounding the IC (200× magnification image) (C). Computer aided image analysis of NeuN immunostained sections reveals marked loss of neurons (D) in the IC of mice exposed to H~2~S (*p* \< 0.001, *t*-test). Representative photomicrographs of mice exposed to breathing air or H~2~S, hematoxylin and eosin (A) and NeuN immunohistochemistry (C). Neurons in the IC region of the H~2~S exposed mice on day 7 were enumerated and compared to breathing air control (D). Degenerating neurons were visualized with Flouro-Jade C staining (E). Arrow indicates degenerative neurons. Neurodegeneration was not seen in the control group. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](nihms-1007346-f0003){#F3}

![Heatmap of changes in proteomic profile in the IC following acute H~2~S exposure.\
Morpheus rendered Heatmap of determined changes in protein expression at 2 h and on days 2 and 4. Hierarchical clustering by Euclidean distance, row average linkage and grouping of rows by gene ontology for biological process (GOBP). Heatmap displays fold expression values of five (2 h and day 2) or four (day 4) IC tissue samples, and average fold expression values, mouse gene identifiers (gene names), protein names, and GOBP. Red color indicates upregulation of protein expression (above 1.2 fold expression vs. control), whereas blue color indicates downregulation of protein expression (below 0.83 fold expression vs. control) Grey color indicates proteins not identified. Protein expression change were converted into a log2 data display. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](nihms-1007346-f0004){#F4}

![Overall distribution of proteomic profile changes in the IC following H~2~S exposure.\
A) Scatter Plot to display overall distribution of one-sample *t*-test differences in protein expression profiles vs. --Log one-sample t-test *p* values 2 h (red), day 2 (blue), and day 4 (green) following H~2~S exposure. Scatter Plots of one-sample t-test fold protein expression differences vs. --Log one-sample t-test p values from B) 2 h, C) day 2, and D) day 4 of H~2~S exposure. One-sample t-test of significantly modulated proteins in the H~2~S exposure group vs. the control according to fold expression values are displayed with official mouse gene symbols in red. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](nihms-1007346-f0005){#F5}

![Validation of selected protein expression changes in IC following H~2~S exposure. Protein expression was measured by Western blot analysis. Quantitative results are shown in graphs next to Western blot images. Samples were normalized to reference gene, β-Actin. Note the significant increase in Alb and Oxctl and a trend of increased Vim. Data are presented as the mean ± S.E.M. Asterisk (\**p* \< 0.05) indicates a significant difference between H~2~S group and Control group.](nihms-1007346-f0006){#F6}

![Validation of expression changes of three genes at the mRNA level in IC following H~2~S exposure. The transcriptional level of three genes (A; Prkab1, B; Vim, C; Ahsal) was measured by quantitative PCR. Samples were normalized with the reference gene Gapdh. Data are presented as the mean ± S.E.M. Note that only a single acute exposure to H~2~S (2 h) was needed to cause upregulation of gene expression of PkAbl and Vim or downregulation of Ahsal gene expression. Asterisks (\*\*\**p* \< 0.001, \*\**p* \< 0.01, \**p* \< 0.05) indicate a significant difference between H~2~S group and Control group.](nihms-1007346-f0007){#F7}

![Exposure to H~2~S induced hypoxic signaling, Fas signaling and inflammatory response in IC. Expression of Fas, Hif-1α, and Nrf2 in IC were analyzed by Western blot assay (A, B and C). Target protein expression was normalized to β-Actin. Quantification of Fas, Hif-1α, and Nrf2 expressions are shown graphically on the right. Expression of TNF-α was measured by ELISA (D). Note that TNF-α was significantly increased in the IC on day 7. Data are presented as the mean ± S.E.M. Asterisk (\**p* \< 0.05) indicates a significant difference between H~2~S group and Control group.](nihms-1007346-f0008){#F8}

![Overarching scheme of H~2~S induced neurotoxicity in the IC.\
This figure is a summary of the overarching hypothesis of acute H~2~S-induced neurotoxicity. H~2~S activates glutamate excitotoxicity, mitochondrial injury, hypoxia, and a breach of the blood brain barrier, and mitochondrial injury trigger neuronal cell death, neuro-inflammation and oxidative stress which ultimately leads to neurodegeneration. Key pathways uncovered in the present study fit in various nodes in this overarching scheme.](nihms-1007346-f0009){#F9}

###### 

A summary of mass spectrometry and distribution of TMT sample labeling. GA = group A; GB = group B; GC = group C; GD = group D.

  Group            Total mice/animal ID   TMT label   Treatment         Exposure/dose                   Euthanasia
  ---------------- ---------------------- ----------- ----------------- ------------------------------- ------------
  GA control       (n = 5)                            40 min day 1      Inhalation/breathing air        Day 4
                   1,2,3,4,5, pooled      131         15 min day 2                                      
                                                      15 min day 3                                      
                                                      15 min day 4                                      
                                                      \+ 2 h recovery                                   
  GB 1 exposure    (n = 5)                            40 min day 1      Inhalation/650--700 ppm H~2~S   Day 1
                   1                      126         \+ 2 h recovery                                   
                   2                      127                                                           
                   3                      128                                                           
                   4                      129                                                           
                   5                      130                                                           
  GC 2 exposures   (*n* = 5)                          40 min day 1      Inhalation/650--700 ppm H~2~S   Day 2
                   1                      126         15 min day 2                                      
                   2                      127         \+ 2 h recovery                                   
                   3                      128                                                           
                   4                      129                                                           
                   5                      130                                                           
  GD 4 exposures   (*n* = 4)                          40 min day 1      Inhalation/650--700 ppm H~2~S   Day 4
                   1                      126         15 min day 2                                      
                   2                      127         15 min day 3                                      
                   3                      128         15 min day 4                                      
                   4                      130         \+ 2 h recovery                                   

###### 

Table of changes in proteomic profile in IC following acute H~2~S exposure.

  Gene names   Protein names                                                          GOBP name                               2h     Day 2   Day 4                                                                   
  ------------ ---------------------------------------------------------------------- --------------------------------------- ------ ------- ------- -------- ------ ------- ------ ---------- ------ ------- ------ --------
  Arpc4        Actin-related protein 2/3 complex subunit 4                            Actin cytoskeleton organization         Up     0.32    0.08    0        Down   −0.26   0.05   0                 0       0.06   0
  Dstn         Destrin                                                                Actin cytoskeleton organization                0       0.11    0        Down   −0.52   0.3    0.0013     Up     0.28    0.12   0.0004
  Iqsecl       IQ motif and SEC7 domain-containing protein 1                          Actin cytoskeleton organization                                         Down   −0.33   0.24   0.0006                           
  Kif2a        Kinesin-like protein                                                   Actin cytoskeleton organization         Down   −0.28   0.1     0                                                               
  Trf          Serotransferrin                                                        Actin cytoskeleton organization                0.26    0.18    0.0003          0.25    0.18   0.0002     Up     0.29    0.06   0
  Lmna         Prelamin-A/C                                                           Adhesion                                                                                                 Up     0.36    0.13   0.0004
  Vim          Vimentin                                                               Adhesion                                Up     0.44    0.24    0.0009                                                          
  Eprs         Bifunctional glutamate/proline-tRNA ligase                             Amine metabolic process                 Down   −0.28   0.16    0.0001                                                          
  Vdac1        Voltage-dependent anion-selective channel protein 1                    Anion transport                                −0.26   0.08    0               −0.08   0.08   0          Down   −0.27   0.19   0.0015
  Gdap1l1      Ganglioside-induced differentiation-associated protein 1-like 1        Axon guidance                           Down   −0.27   0.1     0               0       0.11   0                 −0.05   0.06   0
  Dpysl4       Dihydropyrimidinase-related protein 4                                  Axon guidance                           Down   −0.35   0.19    0.0003                                                          
  Nef1         Neurofilament light polypeptide                                        Axon guidance                           Down   −0.36   0.14    0.0001          −0.19   0.18   0.0002            0.03    0.09   0.0001
  Plp1         Myelin proteolipid protein                                             Axon guidance                           Down   −0.38   0.37    0.0031          −0.04   0.38   0.0042     Down   −0.36   0.23   0.0025
  Alb          Serum albumin                                                          Blood                                   Up     0.37    0.16    0.0002   Up     0.42    0.17   0.0002     Up     0.55    0.12   0.0003
  Hbbt1        Hemoglobin subunit beta-2                                              Blood                                   Up     0.45    0.4     0.0069   Up     0.33    0.23   0.0007     Up     0.49    0.32   0.0066
  Slc2a1       Solute carrier family 2, facilitated glucose transporter member 1      Carbohydrate transport                  Down   −0.28   0.34    0.0024          0.01    0.36   0.0034     Down   −0.37   0.24   0.0029
  Cend1        Cell cycle exit and neuronal differentiation protein 1                 Cell cycle                                     −0.24   0.16    0.0002          −0.13   0.28   0.0012     Up     0.28    0.08   0.0001
  Dnah6        Dynein Axonemal Heavy Chain 6                                          Cell motility                                                           Up     0.41    0.16   0.0002                           
  Ehd3         EH domain-containing protein 3                                         Cellular transport                             0.01    0.14    0.0001          −0.24   0.06   0          Down   −0.21   0.28   0.0045
  Exoc1        Exocyst complex component 1                                            Cellular transport                      Down   −0.26   0.12    0               0.01    0.17   0.0002            0.08    0.07   0.0001
  Lgi3         Leucine-rich repeat LGI family member 3                                Cellular transport                             −0.11   0.17    0.0002          0.07    0.07   0          Up     0.28    0.06   0.0001
  H3f3a        Histone H3.3                                                           DNA metabolism                          Down   −0.34   0.29    0.0014   Down   −0.29   0.22   0.0005            −0.24   0.21   0.0018
  Hist1h3a     Histone H3.1                                                           DNA metabolism                                 −0.09   0.1     0        Down   −0.34   0.17   0.0002            −0.21   0.4    0.0139
  Set          Protein SET                                                            DNA metabolism                          Up     0.33    0.22    0.0006          −0.07   0.09   0                 −0.11   0.09   0.0002
  Atp5j2       ATP synthase subunit f, mitochondrial                                  Energy metabolism                              −0.09   0.08    0        Down   −0.52   0.1    0                 0.04    0.07   0.0001
  Ndufab1      NADH:Ubiquinone Oxidoreductase Subunit AB1                             Energy metabolism                              −0.2    0.11    0        Down   −0.3    0.18   0.0002            −0.04   0.02   0
  Cox6c        Cytochrome c oxidase subunit 6C                                        Energy metabolism                              −0.09   0.15    0.0001          −0.06   0.09   0          Down   −0.44   0.22   0.0021
  Atp6v1g2     V-type proton ATPase subunit G 2                                       Energy metabolism                                                       Down   −0.36   0.11   0          Down   −0.31   0.31   0.0061
  Ndufa13      NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 13        Energy metabolism                              −0.1    0.07    0               −0.26   0.09   0          Down   −0.33   0.12   0.0003
  Atp6v1h      V-type proton ATPase subunit H                                         Energy metabolism                       Down   −0.49   0.21    0.0004          −0.04   0.07   0                 −0.01   0.02   0
  Idh3a        Isocitrate dehydrogenase \[NAD\] subunit alpha, mitochondrial          Energy metabolism                       Down   −0.28   0.04    0               0.04    0.08   0                 0.07    0.05   0
  Mtco2        Cytochrome c oxidase subunit 2                                         Energy metabolism                       Down   −0.34   0.15    0.0001          −0.04   0.1    0                 −0.14   0.12   0.0003
  Atp6v1g1     V-type proton ATPase subunit G 1                                       Energy metabolism                                                                                        Up     0.56    0.22   0.0022
  Me1          Malic enzyme                                                           Energy metabolism                       Down   −0.53   0.09    0                                                               
  Ogdhl        Oxoglutarate Dehydrogenase-Like                                        Energy metabolism                                                              0.09    0.23   0.0006     Up     0.3     0.11   0.0003
  Oxct1        Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial        Energy metabolism                              −0.01   0.07    0               0.06    0.07   0          Up     0.48    0.1    0.0002
  Hsd17b10     3-hydroxyacyl-CoA dehydrogenase type-2                                 Fatty acid and steroid metabolism                                              −0.24   0.14   0.0001     Down   −0.46   0.18   0.0012
  Gpd2         Glycerol-3-phosphate dehydrogenase                                     Glucose metabolism                             −0.01   0.15    0.0001   Up     0.27    0.09   0                 0.2     0.19   0.0013
  Gpi          Glucose-6-phosphate isomerase                                          Glucose metabolism                      Down   −0.46   0.13    0.0001          −0.23   0.07   0                 −0.1    0.01   0
  Pfkp         ATP-dependent 6-phosphofructokinase                                    Glucose metabolism                      Down   −0.35   0.1     0               0.12    0.1    0                 0.05    0.05   0
  Pgam2        Phosphoglycerate mutase 2                                              Glucose metabolism                      Down   −0.39   0.1     0                                                               
  C1qbp        Complement component 1 Q subcomponent-binding protein, mitochondrial   Immune response                                0.03    0.21    0.0004          0.17    0.1    0          Up     0.34    0.08   0.0001
  Mif          Macrophage migration inhibitory factor                                 Immune response                         Down   −0.35   0.16    0.0001          −0.07   0.07   0                 0       0.16   0.0008
  Acat2        Acetyl-CoA acetyltransferase, cytosolic                                Lipid metabolism                               0.03    0.08    0               −0.02   0.24   0.0007     Up     0.34    0.09   0.0002
  Tuba1b       Tubulin alpha-1B chain                                                 Microtubule organization                Down   −0.28   0.09    0               −0.25   0.09   0          Down   −0.31   0.08   0.0001
  Tubb6        Tubulin beta-6 chain                                                   Microtubule organization                                                                                 Down   −0.67   0.1    0.0002
  Mp68         6.8 kDa mitochondrial proteolipid                                      Mitochondrial proteolipid                                               Down   −0.35   0.09   0          Down   −0.4    0.15   0.0007
  Slc25a51     Solute carrier family 25 member 51                                     Mitochondrial transport                 Up     0.35    0.1     0                                                               
  Sccpdh       Saccharopine dehydrogenase-like oxidoreductase                         oxidoreductase                          down   −0.4    0.11    0                                                               
  Pcyt2        Ethanolamine-phosphate cytidylyltransferase                            Phosphatidylethanolamine biosynthesis                                                                    Down   −0.3    0.13   0.0004
  Psmc4        26S protease regulatory subunit 6B                                     Protein degradation                     Down   −0.51   0.12    0                                                               
  Ahsa1        Activator of 90 kDa heat shock protein ATPase homolog 1                Protein folding                         Down   −0.59   0.22    0.0004   Down   −0.35   0.15   0.0001            −0.06   0.08   0.0001
  Hsbp1        Heat shock factor-binding protein 1                                    Protein folding                         Down   −0.3    0.1     0                                                               
  Hspa4l       Heat shock 70 kDa protein 4 L                                          Protein folding                         Down   −0.43   0.03    0               −0.2    0.21   0.0004                           
  Gm8797       Ubiquitin-60S ribosomal protein L40                                    RNA metabolism                          Up     0.46    0.41    0.0078   Up     0.47    0.13   0.0001            0.16    0.13   0.0005
  Hnrnpd       Heterogeneous nuclear ribonucleoprotein D0                             RNA metabolism                          Up     0.3     0.15    0.0001                                           −0.1    0.12   0.0004
  Pcbp1        Poly(rC)-binding protein 1                                             RNA metabolism                          Down   −0.49   0.11    0               −0.16   0.1    0                 −0.2    0.14   0.0006
  Pabpc2       Polyadenylate-binding protein                                          RNA metabolism                          Down   −0.29   0.16    0.0001                                                          
  Hnrnpl       Heterogeneous nuclear ribonucleoprotein L                              RNA metabolism                          Down   −0.4    0.29    0.0013                                                          
  Rps20        40S ribosomal protein S20                                              RNA metabolism                                                                                           Down   −0.31   0.13   0.0005
  Rp17         60S ribosomal protein L7                                               RNA metabolism                          Down   −0.45   0.13    0.0001          −0.08   0.08   0                 −0.16   0.07   0.0001
  Pcbp2        Poly(rC)-binding protein 2                                             RNA metabolism                          Down   −0.63   0.17    0.0002          0.02    0.03   0                 0.17    0.04   0
  Git1         ARF GTPase-activating protein GIT1                                     Signaling                                      0.04    0.08    0        Up     0.34    0.13   0.0001                           
  Arf3         ADP-ribosylation factor 3                                              Signaling                                      −0.03   0.05    0               −0.09   0.08   0          Down   −0.38   0.1    0.0002
  Arhgap35     Rho GTPase-activating protein 35                                       Signaling                               Down   −0.27   0.22    0.0005                                                          
  Gnaq         Guanine nucleotide-binding protein G(q) subunit alpha                  Signaling                               Down   −0.3    0.22    0.0004          −0.17   0.12   0                 −0.07   0.06   0
  Rhot1        Mitochondrial Rho GTPase 1                                             Signaling                               Down   −0.33   0.06    0                                                               
  Rab1         Ras-related protein Rab-1A                                             Signaling                               Down   −0.27   0.14    0.0001          0       0.09   0                 0.14    0.07   0.0001
  Plaa         Phospholipase A-2-activating protein                                   Signaling                               Down   −0.69   0.25    0.0006                                                          
  Prkacb       cAMP-dependent protein kinase catalytic subunit beta                   Signaling                               Up     0.53    0.29    0.0021          −0.05   0.08   0                 −0.12   0.09   0.0001
  Synj1        Synaptojanin-1                                                         Synaptic transmission                                                   Down   −0.38   0.16   0.0001            0.16    0.09   0.0001
  Cldn11       Claudin-11                                                             Tight junction component                       −0.21   0.19    0.0003   Down   −0.46   0.23   0.0006            −0.11   0.13   0.0005
  Eef1b2       Elongation factor 1-beta                                               Translation                             Down   −0.29   0.19    0.0003                                           0.21    0.11   0.0002
  Napb         Beta-soluble NSF attachment protein                                    Vesicle transport                       Down   −0.38   0.06    0               −0.09   0.06   0                 −0.02   0.04   0
  Dnm3         Dynamin-3                                                              Vesicle transport                       Down   −0.38   0.13    0.0001                                           0.08    0.05   0
  Vps26b       Vacuolar protein sorting-associated protein 26B                        Vesicle transport                                                       Up     0.31    0.17   0.000223                         
  Sv2a         Synaptic vesicle glycoprotein 2A                                       Vesicle transport                              −0.21   0.12    0.0001          0.08    0.1    0          Up     0.29    0.16   0.0008

Table displays the Perseus processed protein list containing gene names, protein names, GO biological process names, one-sample t-test, and change of significantly modulated proteins on 2 h and days 2 and 4. This table is complimentary to Morpheus rendered Heatmap of determined changes in protein expression on 2 h and days 2 and 4 ([Fig. 4](#F4){ref-type="fig"}).

###### 

Functional annotation of significantly modulated protein expression in the IC following H~2~S exposure at 2h, days 2, and 4. Table displays dysregulated molecular pathways and total number of proteins associated with GO-term definition. Note the similarity in pathways at 2 h and on day 2.

  ID       Name                                                                \#Gene   FDR
  -------- ------------------------------------------------------------------- -------- ------------
  2h                                                                                    
  P00041   Metabotropic glutamate receptor group I pathway                     2        5.31E-01
  P02772   Pyruvate metabolism                                                 1        1.00E + 00
  P00019   Endothelin signaling pathway                                        2        1.00E + 00
  P02746   Heme biosynthesis                                                   1        1.00E + 00
  P00031   Inflammation mediated by chemokine and cytokine signaling pathway   3        1.00E + 00
  P06664   Gonadotropin-releasing hormone receptor pathway                     3        1.00E + 00
  P00024   Glycolysis                                                          1        1.00E + 00
  P04386   Histamine H2 receptor mediated signaling pathway                    1        1.00E + 00
  P05913   Enkephalin release                                                  1        1.00E + 00
  P00017   DNA replication                                                     1        1.00E + 00
  Day 2                                                                                 
  P00041   Metabotropic glutamate receptor group I pathway                     2        5.79E-01
  P00017   DNA replication                                                     2        5.79E-01
  P02772   Pyruvate metabolism                                                 1        1.00E + 00
  P02746   Heme biosynthesis                                                   1        1.00E + 00
  P00019   Endothelin signaling pathway                                        2        1.00E + 00
  P00031   Inflammation mediated by chemokine and cytokine signaling pathway   3        1.00E + 00
  P06664   Gonadotropin-releasing hormone receptor pathway                     3        1.00E + 00
  P00024   Glycolysis                                                          1        1.00E + 00
  P04386   Histamine H2 receptor mediated signaling pathway                    1        1.00E + 00
  P05913   Enkephalin release                                                  1        1.00E + 00
  Day 4                                                                                 
  P00029   Huntington disease                                                  2        1.00E + 00
  P00020   FAS signaling pathway                                               1        1.00E + 00
  P06664   Gonadotropin-releasing hormone receptor pathway                     2        1.00E + 00
  P00016   Cytoskeletal regulation by Rho GTPase                               1        1.00E + 00

[^1]: Present addresses: Poojya Anantharam: Medical Countermeasures, MRI Global, Kansas City, MO, USA.

[^2]: Present addresses: Belinda Mahama: Neuroscience, Brown University, Rhode Island, Providence, USA.
